How Does Your Medication Work?

Entyvio (vedolizumab) blocks a protein on the surface of white blood cells that get into the gut and cause inflammation in ulcerative colitis and Crohn’s disease. By doing this, the amount of inflammation is reduced.1

Entyvio

About Your Medication

About Your Medication

Entyvio is used to treat the signs and symptoms in adults of:1

Ulcerative Colitis (UC) – Adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor alpha (TNFα) antagonist.

Crohn’s Disease (CD) – Adult patients with moderately to severely active Crohn’s disease who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a tumour necrosis factor alpha (TNFα) antagonist.

LEARN MORE

If you have been prescribed Entyvio and get any side effects, talk to your doctor, pharmacist or nurse.
This includes any possible side effects not listed within this website or in the Patient Information Leaflet.

Adverse events should be reported. In the United Kingdom, reporting forms and information can be found at www.mhra.gov.uk/yellowcard.

Adverse events should also be reported to Takeda on 01628 537900 or e-mail DSO-UK@takeda.com